Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FL018
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,605
Award facts
- Contract value 100% obligated
- $15,605.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,605.34 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml formulation. This firm fixed-price, non-set-aside contract was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 and extending through December 31, 2031.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, supplies this biologic medication to support defense medical supply chain operations. Cosentyx, an immunosuppressant used to treat autoimmune conditions, represents one product within the extensive portfolio of brand-name and generic pharmaceuticals, vaccines, and medical supplies the contractor delivers to the Department of Defense and related federal health agencies. The underlying IDC contract vehicle enables flexible procurement of essential pharmaceutical commodities across multiple therapeutic domains to support military treatment facilities and defense healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FL018?
SPE2DR26FL018 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FL018 worth?
The government has obligated $15,605 on SPE2DR26FL018.
Is contract SPE2DR26FL018 an order under another contract?
Yes. SPE2DR26FL018 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL018 competed?
The extent of competition for SPE2DR26FL018 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award